BioPharmSignal logoBioPharmSignal

Biotech News

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update

Rigel Pharmaceuticals (RIGL)Rigel PharmaceuticalsEarnings

RIGL (RIGL) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is rigl.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

RIGLRigel Pharmaceuticals2026-07-28 12:05 EST

Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results

RIGLRigel Pharmaceuticals2026-04-28 12:05 EST

Rigel Announces Conference Call and Webcast to Report First Quarter 2026 Financial Results

SNDXSyndax Pharmaceuticals2026-02-19 12:00 EST

Syndax to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on February 26, 2026

SNDXSyndax Pharmaceuticals2026-04-24 11:00 EST

Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026

RCKTRocket Pharmaceuticals2026-02-26 21:00 EST

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress

IRONDisc Medicine2026-02-26 13:30 EST

Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GERNGeron2026-02-25 12:00 EST

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

KPTIKaryopharm Therapeutics2026-02-12 12:30 EST

Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress

GERNGeron2026-05-06 11:00 EST

Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights

ZNTLZentalis2026-05-12 20:05 EST

Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress

View all latest news

Rigel Pharmaceuticals

Rigel Pharmaceuticals is a specialty pharmaceutical company with a commercial focus in hematology, inflammation, and related rare-disease settings. Its business combines marketed products with selective pipeline work.

Recent company news

RIGLRigel Pharmaceuticals2026-07-28 12:05 EST

Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results

RIGLRigel Pharmaceuticals2026-07-01 12:05 EST

Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer

RIGLRigel Pharmaceuticals2026-06-16 20:01 EST

Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant)

RIGLRigel Pharmaceuticals2026-05-27 12:05 EST

Rigel to Present at the Jefferies Global Healthcare Conference

RIGLRigel Pharmaceuticals2026-05-21 21:17 EST

Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress

Stock data

Close
37.39 USD
Market cap
555.43M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States